Percutaneous CT-guided Radiofrequency Ablation for Renal Cell Carcinoma in von Hippel-Lindau Disease : Midterm Results 1 )

@inproceedings{Gobara2016PercutaneousCR,
  title={Percutaneous CT-guided Radiofrequency Ablation for Renal Cell Carcinoma in von Hippel-Lindau Disease : Midterm Results 1 )},
  author={Hideo Gobara and Takao Hiraki and Toshihiro Iguchi and Hiroyasu Fujiwara and Yasutomo Nasu and Susumu Kanazawa},
  year={2016}
}
Purpose: To evaluate the safety and midterm results of radiofrequency (RF) ablation for the treatment of renal cell carcinoma (RCC) in patients with von Hippel-Lindau (VHL) disease. Materials and methods: This study included 13 patients with VHL (8 women and 5 men; mean age: 35.5 years) and RCC. Each patient presented with 1-6 RCCs (mean: 2.4 ± 1.7) without extrarenal metastasis. The mean tumor diameter was 18.0 ± 5.0 mm. Transcatheter arterial embolization was performed for 5 (16.7%) of 31… CONTINUE READING